Skip to main content
Top
Published in: Diagnostic Pathology 1/2015

Open Access 01-12-2015 | Case Report

Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis

Published in: Diagnostic Pathology | Issue 1/2015

Login to get access

Abstract

Tumours of ovarian-epithelial type of the testis, including serous borderline tumours, represent very rare entities. They are identical to the surface epithelial tumours of the ovary and have been reported in patients from 14 to 68 years of age. We describe two cases of a 46- and a 39-year old man with incidental findings of intratesticular masses of the left respectively right testis. Under the assumption of a malignant testicular tumour the patients were subjected to inguinal orchiectomy. Histologically, the tumours were identical to their ovarian counterparts: They showed a cystic configuration with a fibrous wall and irregular papillary structures lined by partially multistratified columnar cells and areas of hobnail cells. Furthermore, there was mild cytological atypia with a proliferative activity of below 5 % as proved by Ki67 staining; mitoses could not be detected. Immunohistochemically, the tumour cells displayed expression of pan-cytokeratin AE3, progesterone receptor, Wilms’ tumour protein (WT1), and PAX8 (Paired box gene 8). Estrogen receptor was expressed in one case. Octamer-binding transcription factor-4 (OCT4), calretinin, thrombomodulin, and D2-40 were not expressed. Mutation testing of BRAF revealed a BRAF V600E mutation in one case, while testing for KRAS mutations proved to be negative in both. The BRAF mutated tumour showed strong cytosolic and membranous positivity for B-Raf also on immunohistochemical analysis. Comparative genomic hybridization of one case could not reveal any chromosomal aberrations.
Literature
1.
go back to reference Ibrahim AS, Li C, Al-Jafari MS. Borderline serous papillary tumour of the testis: a case report and review of the literature. Anticancer Res. 2012;32(11):5011–3.PubMed Ibrahim AS, Li C, Al-Jafari MS. Borderline serous papillary tumour of the testis: a case report and review of the literature. Anticancer Res. 2012;32(11):5011–3.PubMed
4.
go back to reference Ulbright T, Young R. Tumors of the testis and adjacent structures. AFIP atlas of tumor pathology vol 4. American Registry of Pathology: Silver Spring, Maryland; 2013. Ulbright T, Young R. Tumors of the testis and adjacent structures. AFIP atlas of tumor pathology vol 4. American Registry of Pathology: Silver Spring, Maryland; 2013.
6.
go back to reference Axiotis CA. Intratesticular serous papillary cystadenoma of low malignant potential: an ultrastructural and immunohistochemical study suggesting mullerian differentiation. Am J Surg Pathol. 1988;12(1):56–63.PubMedCrossRef Axiotis CA. Intratesticular serous papillary cystadenoma of low malignant potential: an ultrastructural and immunohistochemical study suggesting mullerian differentiation. Am J Surg Pathol. 1988;12(1):56–63.PubMedCrossRef
8.
go back to reference Remmele W, Kaiserling E, Zerban U, Hildebrand U, Bennek M, Jacobi-Nolde P, et al. Serous papillary cystic tumor of borderline malignancy with focal carcinoma arising in testis: case report with immunohistochemical and ultrastructural observations. Hum Pathol. 1992;23(1):75–9.PubMedCrossRef Remmele W, Kaiserling E, Zerban U, Hildebrand U, Bennek M, Jacobi-Nolde P, et al. Serous papillary cystic tumor of borderline malignancy with focal carcinoma arising in testis: case report with immunohistochemical and ultrastructural observations. Hum Pathol. 1992;23(1):75–9.PubMedCrossRef
9.
go back to reference Olla L, Di Naro N, Puliga G, Tolu GA. Intraparenchymal serous papillary cystadenoma of the testis: a case report. Pathologica. 2013;105(1):15–7.PubMed Olla L, Di Naro N, Puliga G, Tolu GA. Intraparenchymal serous papillary cystadenoma of the testis: a case report. Pathologica. 2013;105(1):15–7.PubMed
10.
go back to reference Michal M, Kazakov DV, Kacerovska D, Kuroda N, Lovric E, Wachter DL, et al. Paratesticular cystadenomas with ovarian stroma, metaplastic serous Mullerian epithelium, and male adnexal tumor of probable wolffian origin: A series of 5 hitherto poorly recognized testicular tumors. Ann Diagn Pathol. 2013;17(2):151–8. doi:10.1016/j.anndiagpath.2012.09.002.PubMedCrossRef Michal M, Kazakov DV, Kacerovska D, Kuroda N, Lovric E, Wachter DL, et al. Paratesticular cystadenomas with ovarian stroma, metaplastic serous Mullerian epithelium, and male adnexal tumor of probable wolffian origin: A series of 5 hitherto poorly recognized testicular tumors. Ann Diagn Pathol. 2013;17(2):151–8. doi:10.​1016/​j.​anndiagpath.​2012.​09.​002.PubMedCrossRef
12.
13.
go back to reference Helou K, Padilla-Nash H, Wangsa D, Karlsson E, Osterberg L, Karlsson P, et al. Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors. Cancer Genet Cytogenet. 2006;170(1):1–8. doi:10.1016/j.cancergencyto.2006.04.010.PubMedCrossRef Helou K, Padilla-Nash H, Wangsa D, Karlsson E, Osterberg L, Karlsson P, et al. Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors. Cancer Genet Cytogenet. 2006;170(1):1–8. doi:10.​1016/​j.​cancergencyto.​2006.​04.​010.PubMedCrossRef
15.
go back to reference Mayr D, Kanitz V, Anderegg B, Luthardt B, Engel J, Lohrs U, et al. Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays. Am J Clin Pathol. 2006;126(1):101–9. doi:10.1309/N6X5-MB24-BP42-KP20.PubMedCrossRef Mayr D, Kanitz V, Anderegg B, Luthardt B, Engel J, Lohrs U, et al. Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays. Am J Clin Pathol. 2006;126(1):101–9. doi:10.​1309/​N6X5-MB24-BP42-KP20.PubMedCrossRef
16.
go back to reference Hauptmann S, Denkert C, Koch I, Petersen S, Schluns K, Reles A, et al. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum Pathol. 2002;33(6):632–41.PubMedCrossRef Hauptmann S, Denkert C, Koch I, Petersen S, Schluns K, Reles A, et al. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum Pathol. 2002;33(6):632–41.PubMedCrossRef
17.
go back to reference Staebler A, Heselmeyer-Haddad K, Bell K, Riopel M, Perlman E, Ried T, et al. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum Pathol. 2002;33(1):47–59.PubMedCrossRef Staebler A, Heselmeyer-Haddad K, Bell K, Riopel M, Perlman E, Ried T, et al. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum Pathol. 2002;33(1):47–59.PubMedCrossRef
18.
go back to reference Wolf NG, Abdul-Karim FW, Farver C, Schrock E, du Manoir S, Schwartz S. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer. 1999;25(4):307–15.PubMedCrossRef Wolf NG, Abdul-Karim FW, Farver C, Schrock E, du Manoir S, Schwartz S. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer. 1999;25(4):307–15.PubMedCrossRef
19.
go back to reference Singer G, Oldt 3rd R, Cohen Y, Wang BG, Sidransky D, Kurman RJ, et al. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst. 2003;95(6):484–6.PubMedCrossRef Singer G, Oldt 3rd R, Cohen Y, Wang BG, Sidransky D, Kurman RJ, et al. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst. 2003;95(6):484–6.PubMedCrossRef
20.
go back to reference Bosmuller H, Fischer A, Pham DL, Fehm T, Capper D, von Deimling A, et al. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR. Hum Pathol. 2013;44(3):329–35. doi:10.1016/j.humpath.2012.07.010.PubMedCrossRef Bosmuller H, Fischer A, Pham DL, Fehm T, Capper D, von Deimling A, et al. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR. Hum Pathol. 2013;44(3):329–35. doi:10.​1016/​j.​humpath.​2012.​07.​010.PubMedCrossRef
22.
go back to reference Emmanuel C, Chiew YE, George J, Etemadmoghadam D, Anglesio MS, Sharma R, et al. Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. Clin Cancer Res. 2014;20(24):6618–30. doi:10.1158/1078-0432.CCR-14-1292.PubMedCrossRef Emmanuel C, Chiew YE, George J, Etemadmoghadam D, Anglesio MS, Sharma R, et al. Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. Clin Cancer Res. 2014;20(24):6618–30. doi:10.​1158/​1078-0432.​CCR-14-1292.PubMedCrossRef
23.
go back to reference Cundell D, Pawade J, Sohail M, Melegh Z. V600e BRAF mutation in a borderline serous tumour of the testis is genotypic evidence of similarity with phenotypic ovarian counterpart. Histopathology. 2014. doi:10.1111/his.12630.PubMed Cundell D, Pawade J, Sohail M, Melegh Z. V600e BRAF mutation in a borderline serous tumour of the testis is genotypic evidence of similarity with phenotypic ovarian counterpart. Histopathology. 2014. doi:10.​1111/​his.​12630.PubMed
Metadata
Title
Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis
Publication date
01-12-2015
Published in
Diagnostic Pathology / Issue 1/2015
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-015-0342-9

Other articles of this Issue 1/2015

Diagnostic Pathology 1/2015 Go to the issue